Matrix metallopropteinases in heart failure

Area of Science:

• Cardiology
• Biochemistry

Background:

• Heart failure (HF) involves myocardial structural and functional abnormalities.
• Matrix metalloproteinases (MMPs) are implicated in left ventricular dysfunction, adverse remodeling, and prognosis post-myocardial infarction.
• Oxidative stress is strongly associated with MMPs in HF pathophysiology.

Purpose of the Study:

• To explore the role of matrix metalloproteinases (MMPs) in the pathogenesis and pathophysiology of heart failure (HF).
• To review potential therapeutic agents targeting the MMP pathway in HF management.

Main Methods:

• Literature review of studies investigating MMPs in heart failure.
• Analysis of the association between oxidative stress and MMPs in HF.
• Examination of classical and novel agents affecting MMPs.

Main Results:

• MMPs are significantly associated with left ventricular dysfunction and adverse remodeling in HF.
• Oxidative stress plays a key role in the MMPs' contribution to HF.
• Several agents, including statins, ACE inhibitors, and beta-blockers, may modulate MMPs.

Conclusions:

• Matrix metalloproteinases are crucial in HF pathogenesis and progression.
• Modulating MMPs via existing or novel therapeutic agents represents a promising future strategy for HF treatment.